References

Asako, O., I. Katsumi, K. Kizuhiro, S. Haruki, H. Tsutomu and S. Masayuki, 2004. Canine adiponectin: Measurement of its serum/plasma concentration by ELISA and effects of obesity. Vet. Biochem., 41: 31-37.
Direct Link  |  

Berg, A.H. and P.E. Scherer, 2005. Adipose tissue, inflammation and cardiovascular disease. Circ. Res., 96: 939-949.
PubMed  |  Direct Link  |  

Berg, A.H., T.P. Combs, X. Du, M. Brownlee and P.E. Scherer, 2001. The adipocyte secreted protein Acrp30 enhances hepatic insulin action. Nat. Med., 7: 947-953.
Direct Link  |  

Chandran, M., T. Ciaraldi, S.A. Phillips and R.R. Henry, 2003. Adiponectin: More than just another fat cell hormone? Diabetes Care, 26: 2442-2450.
CrossRef  |  PubMed  |  Direct Link  |  

Downs, L.G., S.M. Crispin, V. LeGrande-Defretin, G. Perez-Camargo, T. McCappin and C.H. Bolton, 1997. The influence of lifestyle and diet on the lipoprotein profile of Border Collies. Res. Vet. Sci., 63: 35-42.
CrossRef  |  

German, A.J., S.L. Holden, T. Bissot, R.M. Hackett and V. Biourge, 2007. Dietary energy restriction and successful weight loss in obese client-owned dogs. J. Vet. Int. Med., 21: 1174-1180.
CrossRef  |  

Ghazanfari, S., K. Nobari and T. Yamauchi, 2011. Adiponectin: A novel hormone in birds. Asian J. Anim. Vet. Adv., 6: 429-439.
CrossRef  |  

Hsiao, P.J., K.K. Kuo, S.J. Shin, Y.H. Yang and W.Y. Lin et al., 2007. Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J. Gastroenterol. Hepatol., 22: 2118-2123.
PubMed  |  

IDF, 2005. The IDF consensus worldwide definition of the metabolic syndrome. IDF Promoting diabetes care, prevention and a cure worldwide, http://www.idf.org/webdata/docs/Metac_syndrome_def.pdf.

Iacobellis, G., A.M. Pellicelli, B. Grisorio, G. Barbarini, F. Leonetti, A.M. Sharma and G. Barbaro, 2008. Relation of epicardial fat alanine aminotransferase in subjects with increased visceral fat. Obesity, 16: 179-183.
CrossRef  |  

Ishioka, K., A. Omachi, M. Sagawa, H. Shibata, T. Honjoh, K. Kimura and M. Saito, 2006. Canine adiponectin: CDNA structure, mRNA expression in adipose tissues and reduced plasma level in obesity. Res. Vet. Sci., 80: 127-132.
CrossRef  |  

Kondo, H., I. Shimomura, Y. Matsukawa, M. Kumada and M. Takahashi et al., 2002. Association of adiponectin mutation with type 2 diabetes: A candidate gene for the insulin resistance syndrome. Diabetes, 51: 2325-2328.
CrossRef  |  Direct Link  |  

Kumada, M., S. Kihara, N. Ouchi, H. Kobayashi and Y. Okamoto et al., 2004. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation, 109: 2046-2049.
Direct Link  |  

Lund, E.M., P.J. Armstrong, C.A. Kirk and J.S. Klausner, 2006. Prevalence and risk factors for obesity in adult dogs from private US veterinary practices. Int. J. Applied Res. Vet. Med., 4: 177-186.
Direct Link  |  

Magori, E., M. Nakamura, A. Inoue, A. Tanaka and N. Sasaki et al., 2005. Malate dehydrogenase activities are lower in some types of peripheral leucocytes of dogs and cats with type 1 diabetes mellitus. Res. Vet. Sci., 78: 39-44.
CrossRef  |  Direct Link  |  

Mori, N., P. Lee, I. Yamamoto, S. Nozawa and T. Arai, 2011. Insulin Treatment-Induced Daily Changes to Plasma Adiponectin and TNF-α Level and Lipid Metabolism Parameters in Dogs Suffering from Type 1 Diabetes Mellitus Asian J. Anim. Vet. Adv., 6: 844-850.
CrossRef  |  

Neumann, S., H. Welling, T. Bilzer and S. Thuere, 2008. Myopathy and alterations in serum 3-methylhistidine in dogs with liver disease. Res. Vet. Sci., 84: 178-184.
CrossRef  |  

Pasarica, M., Y.D. Tchoukalova, L.K. Heilbronn, X. Fang and J.B. Albu et al., 2009. Differential effect of weight loss on adipocyte size subfractions in patients with type 2 diabetes. Obesity, 17: 1976-1978.
CrossRef  |  

Pitkanen, O.M., H. Vanhanen and E. Ptkanen, 1999. Metabolic syndrome is associated with changes in D-mannose metabolism. Scand. J. Clin. Lab. Invest., 59: 607-612.
PubMed  |  

Saltiel, A.R., 2001. You are what you secrete. Nat. Med., 7: 887-888.
PubMed  |  

Verkest, K.R., L.M. Fleeman, J.M. Morton, K. Ishioka and J.S. Rand, 2011. Compensation for obesity-induced insulin resistance in dogs: Assessment of the effects of leptin, adiponectin and glucagon-like peptide-1 using path analysis. Domestic Anim. Endocrinol., 41: 24-34.
CrossRef  |  PubMed  |  Direct Link  |  

Weyer, C., T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley and P.A. Tataranni, 2001. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrine Metab., 86: 1930-1935.
CrossRef  |  PubMed  |  

Yamauchi, T., J. Kamon, Y. Minokoshi, Y. Ito and H. Waki et al., 2002. Adiponectin stimulates glucose utilization and fatty acid oxidation by activating AMP-activated protein kinase. Nat. Med., 8: 1288-1295.
CrossRef  |  Direct Link  |